王敬. 高通量透析治疗慢性肾衰竭尿毒症患者的效果评价[J]. 蚌埠医科大学学报, 2016, 41(4): 464-466. DOI: 10.13898/j.cnki.issn.1000-2200.2016.04.012
    引用本文: 王敬. 高通量透析治疗慢性肾衰竭尿毒症患者的效果评价[J]. 蚌埠医科大学学报, 2016, 41(4): 464-466. DOI: 10.13898/j.cnki.issn.1000-2200.2016.04.012
    WANG Jing. Clinical effect of high flux hemodialysis in the treatment of uremic patients with chronic renal failure[J]. Journal of Bengbu Medical University, 2016, 41(4): 464-466. DOI: 10.13898/j.cnki.issn.1000-2200.2016.04.012
    Citation: WANG Jing. Clinical effect of high flux hemodialysis in the treatment of uremic patients with chronic renal failure[J]. Journal of Bengbu Medical University, 2016, 41(4): 464-466. DOI: 10.13898/j.cnki.issn.1000-2200.2016.04.012

    高通量透析治疗慢性肾衰竭尿毒症患者的效果评价

    Clinical effect of high flux hemodialysis in the treatment of uremic patients with chronic renal failure

    • 摘要: 目的:观察高通量透析治疗慢性肾衰竭尿毒症患者的临床效果。方法:选择120例慢性肾衰竭尿毒症患者,随机分为观察组和对照组,观察组患者给予高通量透析治疗,对照组给予普通血液透析治疗。比较2组患者的治疗效果。结果:观察组患者经治疗后总有效率为90.0%,高于常规透析治疗的总有效率70.0%(P<0.01)。2组患者透析后尿素氮(BUN)、血肌酐(Scr)、β2微球蛋白(β2-MG)和甲状旁腺素(PTH)均较各自透析前显著降低(P<0.01)。观察组患者透析后的BUN、β2-MG和PTH降低幅度均显著高于对照组(P<0.01),而Scr降低幅度明显低于对照组(P<0.01)。观察组患者透析后体质量增加率明显高于对照组(P<0.01),而骨关节痛、疲乏、皮肤瘙痒的发生率均低于对照组(P<0.05~P<0.01)。结论:高通量透析治疗慢性肾衰竭尿毒症患者,能提高治疗效果,对血液中的大、中、小分子毒素均有较强的清除作用,能改善透析后不良反应发生率,提高患者生存质量,疗效确切,值得推广。

       

      Abstract: Objective: To observe the clinical effects of high flux hemodialysis in the treatment of uremic patients with chronic renal failure. Methods: One hundred and twenty uremic patients with chronic renal failure were randomly divided into the observation group and control group. The observation group and control group were treated with high flux dialysis and conventional hemodialysis, respectively. Results: The total effective rate in observation group(90.0%) was higher than that in control group after treatment(70.0%)(P<0.01). The levels of BUN, Scr, β2-MG and PTH in two groups after dialysis were significantly lower than those in before dialysis(P<0.01). BUN、β2-MG and PTH in observation group decreased significantly higher than the control group(P<0.01) after dialysis, while the Scr is oppsite(P<0.01). After dialysis, the number of cases with body mass index increasing in observation group was significantly higher than that in control group(P<0.01). and the incidence rates of bone and joint pain, fatigue and skin pruritus in observation group were lower than those in control group(P<0.05 to P<0.01). Conclusions: The treatment of uremia patients with chronic renal failure with high flux dialysis can improve the therapeutic effect, strongly clear the large, middle and small molecules, reduce the incidence rate of adverse reactions and improve the life quality of patients, which is worthy of promoting in clinic use.

       

    /

    返回文章
    返回